Prostate cancer

You are here: 

Bisphosphonate therapy for prostate cancer

Bisphosphonate therapy is a systemic therapy that may be used in the treatment of prostate cancer to strengthen bone.

Bisphosphonate therapy may be used:

  • to relieve bone pain or to prevent fractures in advanced hormone-refractory prostate cancer (palliative therapy)
  • to prevent osteoporosis in men receiving hormonal therapy

Bisphosphonates are used in combination with other standard treatments for hormone-refractory prostate cancer.

The bisphosphonate used to treat hormone-refractory prostate cancer is:

  • zoledronic acid (Zometa)
    • Zoledronic acid is used to treat men who have little or no pain from bone metastases.
    • This drug is effective in reducing the number of skeletal related events, including bone fractures and the need for radiation to bone metastases.
    • This drug also reduces pain related to bone metastases.
    • The drug has a number of side effects, and men should be informed of the risks and benefits of taking zoledronic acid.

Stories

Ray Ellis in fireman gear Because of smoke inhalation and exposure to toxic chemicals, I live with the fear of cancer virtually every day.

Read Ray's story

Buy a daffodil pin

Daffodil pin

The daffodil is a symbol of strength and courage in the fight against cancer. Buy a daffodil pin and wear it in April to show your support for Canadians living with cancer.

Learn more